Bacille Calmette-Guérin revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection.

Bacille Calmette-Guérin (BCG) revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection, defined by sustained QuantiFERON-TB (QFT) test conversion ...

While the top- and bottom-line numbers for Qiagen (QGEN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to ...

Our QuantiFERON tuberculosis test also delivered another strong quarter of double-digit sales growth as we continue to drive the transition to blood-based testing for TB testing from the outdated ...

QIAGEN N.V.’s (QGEN - Free Report) first-quarter 2025 adjusted earnings per share (EPS) were 55 cents, and 56 cents at ...

Diagnostic solutions registered the highest growth, driven by strong demand for QuantiFERON and QIAstat-Dx. PCR/Nucleic acid amplification technologies also posted solid growth, supported by the ...

Getting the BCG shot in the trial did induce T-cell response but without an impact on sustained conversion to a positive ...

The aim of the present work was to evaluate the usefulness of the interferon-gamma release assays (IGRAs): QuantiFERON-tuberculosis (TB) Gold-In-Tube test (QFG) and T-SPOT.TB for the diagnosis of ...